NAPSA
| Name | Synonyms | Full Name | RefSeq ID | Description (.pdf) | IGV-img (humangenome) | Sashimi-img (humangenome) | UCSC-img (humangenome) | IGV-img (batgenome) |
|---|---|---|---|---|---|---|---|---|
| NAPSA | NAP1, NAPA, Kdap, KAP | napsin A aspartic peptidase | NM_004851 | NONE | NONE | NONE |
Download all snapshots for IGV, UCSC and Sashimi (zip archive)
Description
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus. No expression in human but very low expression in bat.
Maximum read counts and DESeq normalized read counts for human and bat cell lines
| Source | Species | Mapping on | Mock3h | Mock7h | Mock23h | EBOV3h | EBOV7h | EBOV23h | MARV3h | MARV7h | MARV23h | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Read_Max | H. sapiens | Genome | 0 | 2 | 2 | 1 | 1 | 0 | 2 | 2 | 0 | |
Read_Max | R. aegyptiacus | Transcriptome | 12 | 5 | 15 | 8 | 8 | 10 | 5 | 6 | 17 | |
Read_Max | R. aegyptiacus | Genome | 7 | 9 | 9 | 7 | 7 | 6 | 6 | 15 | 12 | |
DESeq | H. sapiens | Genome | 1.0 | 3.04 | 4.97 | 1.0 | 3.44 | 1.0 | 2.75 | 4.2 | 1.0 | |
DESeq | R. aegyptiacus | Transcriptome | 34.61 | 22.78 | 80.4 | 46.78 | 44.8 | 30.51 | 26.59 | 36.53 | 63.98 | |
DESeq | R. aegyptiacus | Genome | 52.42 | 86.71 | 142.82 | 57.27 | 91.52 | 82.24 | 79.84 | 96.74 | 111.3 |